Dr. Reddy's (RDY) to Begin Phase III Study on Sputnik Vaccine Zacks Equity Research - Zacks - Mon Jan 18, 8:38AM CST Zacks Equity Research - ZACKS - Mon Jan 18, 8:38AM CST
Dr. Reddy's (RDY) receives approval from the DCGI to conduct a phase III study on the Sputnik V vaccine for the treatment of COVID-19 in India.
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know Zacks Equity Research - Zacks - Wed Jan 13, 4:45PM CST Zacks Equity Research - ZACKS - Wed Jan 13, 4:45PM CST
Moderna (MRNA) closed at $124.06 in the latest trading session, marking a -0.39% move from the prior day.
Stock Market News for Jan 13, 2021 Zacks Equity Research - Zacks - Wed Jan 13, 9:21AM CST Zacks Equity Research - ZACKS - Wed Jan 13, 9:21AM CST
Benchmarks closed in the positive territory on Tuesday as investors remained optimistic on possible fiscal stimulus and vaccine roll out.
Thinking about trading options or stock in Nio, Ford Motor, Johnson & Johnson, Moderna, or General Motors? PR Newswire - PRF - Wed Jan 13, 8:31AM CST CMTX - Wed Jan 13, 8:31AM CST
, /PRNewswire/ --Â InvestorsObserver issues critical PriceWatch Alerts for NIO, F, JNJ, MRNA, and GM.
Flat Session Gets Market Back in the Green Jim Giaquinto - Zacks - Wed Jan 13, 12:15AM CST Jim Giaquinto - ZACKS - Wed Jan 13, 12:15AM CST
Flat Session Gets Market Back in the Green
Markets Prove Buoyant; KB Home (KNH) Beats Q4 Estimates Mark Vickery - Zacks - Tue Jan 12, 4:52PM CST Mark Vickery - ZACKS - Tue Jan 12, 4:52PM CST
KB Home's $1.12 per share was well out in front of the 87 cents in the Zacks consensus, while revenues of $1.19 billion topped the $1.11 billion expected.
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis Sweta Jaiswal, Frm - Zacks - Tue Jan 12, 12:16PM CST Sweta Jaiswal, Frm - ZACKS - Tue Jan 12, 12:16PM CST
The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.
COVID-19 Vaccine Production to Ramp Up Zacks Equity Research - Zacks - Tue Jan 12, 9:37AM CST Zacks Equity Research - ZACKS - Tue Jan 12, 9:37AM CST
COVID-19 Vaccine Production to Ramp Up
Covid-19 Vaccinations Promise to Ramp Up Mark Vickery - Zacks - Tue Jan 12, 9:22AM CST Mark Vickery - ZACKS - Tue Jan 12, 9:22AM CST
Guidance for the end of 2020 was to have 20 million Americans with the first half of the two-injection immunization treatment; as of now, only around 9 million Americans have received the first dose.
Moderna (MRNA) Stock Up on Vaccine Pipeline Expansion Plan Zacks Equity Research - Zacks - Tue Jan 12, 8:18AM CST Zacks Equity Research - ZACKS - Tue Jan 12, 8:18AM CST
Moderna (MRNA) plans to initiate clinical studies on new candidates as potential vaccine for seasonal flu, HIV and the Nipah virus.
Jose M. Vega, M.D. Joins Moderna as Chief Safety Officer BusinessWire - Tue Jan 12, 4:00AM CST CMTX - Tue Jan 12, 4:00AM CST
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Jose M. Vega, M.D. joined Moderna as Chief Safety Officer effective...
Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines BusinessWire - Tue Jan 12, 4:00AM CST CMTX - Tue Jan 12, 4:00AM CST
Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Uber Technologies, Inc. (NYSE: UBER), the world's leading ridesharing and delivery platform,...
Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland BusinessWire - Tue Jan 12, 3:59AM CST CMTX - Tue Jan 12, 3:59AM CST
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has authorized...
4 Reasons for Bank ETFs to Win in 2021 Sanghamitra Saha - Zacks - Mon Jan 11, 1:30PM CST Sanghamitra Saha - ZACKS - Mon Jan 11, 1:30PM CST
Bank ETFs should stay strong in the coming days on the back of cheaper valuation, Fed's signal for buybacks, Democrat's control over Senate and spike in bond yields.
Infrastructure and Energy Alternatives, Carrols Restaurant, Moderna, Blueprint Medicines and Halozyme Therapeutics highlighted as Zacks Bull and Bear of the Day Zacks Equity Research - Zacks - Mon Jan 11, 10:22AM CST Zacks Equity Research - ZACKS - Mon Jan 11, 10:22AM CST
Infrastructure and Energy Alternatives, Carrols Restaurant, Moderna, Blueprint Medicines and Halozyme Therapeutics highlighted as Zacks Bull and Bear of the Day
Futures Down as Investors Weigh Covid-19 Cases Against Vaccines Zacks Equity Research - Zacks - Mon Jan 11, 9:54AM CST Zacks Equity Research - ZACKS - Mon Jan 11, 9:54AM CST
Futures Down as Investors Weigh Covid-19 Cases Against Vaccines
Racing Against Time: Covid-19 vs. Vaccines Mark Vickery - Zacks - Mon Jan 11, 9:15AM CST Mark Vickery - ZACKS - Mon Jan 11, 9:15AM CST
This past Friday brought the U.S. its largest single-day amount of Covid-19 cases since the pandemic began in earnest back in March of last year: 310K in a single 24-hour period.
Health Officials Warn Of COVID-19 Vaccine Shortages Across Canada Baystreet.ca - Baystreet - Mon Jan 11, 6:01AM CST Baystreet.ca - BAYSTREET - Mon Jan 11, 6:01AM CST
Health authorities across Canada are warning that they’re running low on COVID-19 vaccines.
The ...
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines BusinessWire - Mon Jan 11, 3:20AM CST CMTX - Mon Jan 11, 3:20AM CST
--HIV vaccine program to accelerate human validation of novel vaccination strategies
Thinking about trading options or stock in Baidu, Moderna, Micron Technology, Riot Blockchain, or New Relic? PR Newswire - PRF - Fri Jan 8, 8:31AM CST CMTX - Fri Jan 8, 8:31AM CST
, /PRNewswire/ --Â InvestorsObserver issues critical PriceWatch Alerts for BIDU, MRNA, MU, RIOT, and NEWR.
